These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2426078)

  • 1. [Symptomatic irradiation therapy of the spleen in advanced osteomyelosclerosis].
    Slanina J; Vondraczek A; Wannenmacher M
    Dtsch Med Wochenschr; 1986 Jul; 111(30):1144-50. PubMed ID: 2426078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Splenic irradiation in the treatment of idiopathic myelofibrosis. Retrospective study of 14 cases].
    Sciascia R; Mazza P; Tondi L
    Radiol Med; 1988; 76(1-2):87-90. PubMed ID: 3399713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for splenomegaly.
    Mod H; Prasiko G; Jha AK; Chaurasia PP; Srivastava R
    JNMA J Nepal Med Assoc; 2005; 44(159):97-9. PubMed ID: 16554863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
    Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
    Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience.
    Pistevou-Gombaki K; Zygogianni A; Kantzou I; Kyrgias G; Mystakidou K; Kouvaris J; Klonizakis I; Tsirigotis P; Pappa V; Siakantari M; Eleftheriadis N; Georgakopoulos J; Sarris G; Kelekis N; Kouloulias V
    J BUON; 2015; 20(4):1132-6. PubMed ID: 26416067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Splenomegalic osteomyelosclerosis with myeloid metaplasia and generalized sclerosis].
    Vilcu A
    Rev Med Chir Soc Med Nat Iasi; 1972; 16(3):701-6. PubMed ID: 5080563
    [No Abstract]   [Full Text] [Related]  

  • 8. Repeated and preemptive palliative radiotherapy of symptomatic hepatomegaly in a patient with advanced myelofibrosis.
    Riesterer O; Gmür J; Lütolf U
    Onkologie; 2008 Jun; 31(6):325-7. PubMed ID: 18547974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative irradiation of the spleen.
    McFarland JT; Kuzma C; Millard FE; Johnstone PA
    Am J Clin Oncol; 2003 Apr; 26(2):178-83. PubMed ID: 12714892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Splenic megakaryocytic metaplasia in osteomyelosclerosis--case report].
    Polko M; Polanowicz U; Górka A
    Wiad Lek; 1993 Jun; 46(11-12):452-5. PubMed ID: 8116295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients.
    Kitanaka A; Takenaka K; Shide K; Miyamoto T; Kondo T; Ozawa K; Kurokawa M; Akashi K; Shimoda K
    Int J Hematol; 2016 Apr; 103(4):423-8. PubMed ID: 26791378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irradiation for control of hypersplenism and painful splenomegaly in myeloid metaplasia.
    Greenberger JS; Chaffey JT; Rosenthal DS; Moloney WC
    Int J Radiat Oncol Biol Phys; 1977; 2(11-12):1083-90. PubMed ID: 74374
    [No Abstract]   [Full Text] [Related]  

  • 13. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.
    Elliott MA; Chen MG; Silverstein MN; Tefferi A
    Br J Haematol; 1998 Nov; 103(2):505-11. PubMed ID: 9827926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective management of accelerated phase myelofibrosis with low-dose splenic radiotherapy.
    Pardanani A; Brown P; Neben-Wittich M; Tobin R; Tefferi A
    Am J Hematol; 2010 Sep; 85(9):715-6. PubMed ID: 20661915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Splenic irradiation in myeloid hemopathies: evaluation and toxicity].
    Gonzague-Casabianca L; Bouabdallah R; Cowen D; Alzieu C; Richaud P; Resbeut M
    Cancer Radiother; 1997; 1(3):213-21. PubMed ID: 9295875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience.
    Soldić Z; Murgić J; Jazvić M; Radić J; Bolanca A; Stancić V; Kusić Z
    Acta Clin Croat; 2011 Mar; 50(1):29-35. PubMed ID: 22034781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myelofibrosis with myeloid metaplasia. A study of 24 consecutive patients].
    Bettini R; Redaelli S; Marzetta K; Maino C; Sala D; Saccà V; Gorini M
    Recenti Prog Med; 2004; 95(7-8):358-64. PubMed ID: 15303545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spleen versus bone marrow in idiopathic myeloid metaplasia].
    Aggio MC
    Sangre (Barc); 1984; 29(3):294-8. PubMed ID: 6207598
    [No Abstract]   [Full Text] [Related]  

  • 20. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.